Navigation Links
UW-Madison scientists to mimic nature for newest cancer drugs

Madison, Wis. - The natural world has been medicine's most effective arsenal, providing life-saving antibiotics and our most potent anti- cancer drugs.

Now, with help from the National Cancer Institute (NCI), a consortium of University of Wisconsin-Madison scientists will embark on a five-year program of drug discovery by copying and improving nature's designs to develop new medici......

Full article >>> > New technologies, together with existing libraries of previously discovered natural compounds, will help the UW-Madison group identify and evaluate molecules that may have value in the fight against cancer. Techniques to genetically manipulate microbes and synthesize their biologically active products, plus novel mouse models of cancer and real-time tumor imaging methods, will underpin much of w......

Full article >>> for the next generation of anti-cancer compounds.

Terry Devitt is science editor for the University Communications department at the University of Wisconsin-Madison.

......

Full article >>>
'"/>

Source:wistechnology.com By Terry Devitt 07/24/05


Related biology technology :

1. UW-Madison to receive $125M for bioenergy research center
2. Three finalists named for UW-Madison CIO
3. UW-Madison launches new high-speed research network
4. UW-Madison approves new research institute
5. UW-Madison dean predicts bio-economy will fuel Wisconsin
6. Scott Converse, UW-Madison School of Business, on the innovation mind-set
7. Scott Converse, UW-Madison School of Business, on IT workforce development
8. UW-Madisons Beebe wins scientific award
9. UW-Madison MBA program ranked among best for investment return
10. UW-Madison gets $333,000 for biofuels research
11. UW-Madison enters Kauffman grant competition
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/20/2017)... ... April 20, 2017 , ... As part of ... explore challenging patient cases when screening for direct oral anticoagulant. When patients taking ... need for bridging parental anticoagulation especially for those at high risk of thrombosis ...
(Date:4/20/2017)...  Eli Lilly and Company (NYSE: LLY ... the prevention of migraine at the American Academy of ... 22-28, 2017, in Boston . ... including safety and patient outcomes data for galcanezumab in ... in monthly migraine headache days among patients with episodic ...
(Date:4/20/2017)... ... April 20, 2017 , ... ... and clinical research community’s growing body of knowledge during its Eighth Annual ... Theatre and the adjacent Darling Atrium. During the event, undergraduates, graduate students, and ...
(Date:4/20/2017)... 20, 2017 /PRNewswire/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: ... the International Liver Congress ("ILC") 2017 of the European Association ... Amsterdam on the positive effects of PBI-4050 on ... obesity and metabolic syndrome. ... According to Dr. Lyne Gagnon, Vice-President of R&D Pre-clinical of ...
Breaking Biology Technology:
(Date:4/11/2017)... Apr. 11, 2017 Research and Markets has ... report to their offering. ... The global eye tracking market to grow at a CAGR of ... Eye Tracking Market 2017-2021, has been prepared based on an in-depth ... market landscape and its growth prospects over the coming years. The ...
(Date:4/5/2017)... Allen Institute for Cell Science today announces the launch ... dynamic digital window into the human cell. The website ... deep learning to create predictive models of cell organization, ... suite of powerful tools. The Allen Cell Explorer will ... resources created and shared by the Allen Institute for ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
Breaking Biology News(10 mins):